Future OPPS Pro-Rata Reductions Limited To 20% Under Senate Bill
This article was originally published in The Gray Sheet
Executive Summary
A medical device industry and hospital-supported bill that sets an outer limit on the level of pro-rata reduction allowed each year under the hospital outpatient prospective payment system (OPPS) is likely to be included into a larger Medicare package later this year
You may also be interested in...
Device Inpatient Payment, Medicare Contractor Reforms Pass With Drug Bill
The Senate will take up Medicare contractor and inpatient prospective payment reform proposals within the "Medicare Modernization and Prescription Drug Act" of 2002 (HR 4954) after the July 4 recess
Device Inpatient Payment, Medicare Contractor Reforms Pass With Drug Bill
The Senate will take up Medicare contractor and inpatient prospective payment reform proposals within the "Medicare Modernization and Prescription Drug Act" of 2002 (HR 4954) after the July 4 recess
Lewin Group Blood Products Reimbursement Study Expected This Summer
An upcoming Lewin Group study commissioned by AdvaMed will identify problem areas in the way hospitals are reimbursed for blood and blood products under the Medicare inpatient prospective payment system (IPPS), the trade group says